S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in

OrganiGram Stock Forecast, Price & News

0.00 (0.00 %)
(As of 01/15/2021 12:00 AM ET)
Today's Range
Now: $1.80
50-Day Range
MA: $1.46
52-Week Range
Now: $1.80
Volume21.18 million shs
Average Volume8.85 million shs
Market Capitalization$417.76 million
P/E RatioN/A
Dividend YieldN/A
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers cannabis flowers, extracts, edibles and oils, beverages, and other cannabis products for adult recreational market under the Edison Reserve, Edison Cannabis Co., ANKR Organics, and Trailblazer brands; and medical cannabis products, including strains, cannabis oils, extracts, edibles, beverages, and vaporizers for the medical market. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
OrganiGram logo


Overall MarketRank

1.58 out of 5 stars

Medical Sector

272nd out of 1,558 stocks

Pharmaceutical Preparations Industry

143rd out of 638 stocks

Analyst Opinion: 4.2Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolNASDAQ:OGI



Sales & Book Value

Annual Sales$64.61 million
Cash Flow$0.02 per share
Book Value$1.04 per share


Net Income$-101,290,000.00
Net Margins-207.26%


Market Cap$417.76 million
Next Earnings Date4/13/2021 (Estimated)
OptionableNot Optionable
0.00 (0.00 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OGI News and Ratings via Email

Sign-up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

OrganiGram (NASDAQ:OGI) Frequently Asked Questions

How has OrganiGram's stock price been impacted by Coronavirus?

OrganiGram's stock was trading at $1.72 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, OGI shares have increased by 4.7% and is now trading at $1.80.
View which stocks have been most impacted by COVID-19

Is OrganiGram a buy right now?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OrganiGram in the last twelve months. There are currently 8 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" OrganiGram stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OGI, but not buy additional shares or sell existing shares.
View analyst ratings for OrganiGram
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than OrganiGram?

Wall Street analysts have given OrganiGram a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but OrganiGram wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is OrganiGram's next earnings date?

OrganiGram is scheduled to release its next quarterly earnings announcement on Tuesday, April 13th 2021.
View our earnings forecast for OrganiGram

How were OrganiGram's earnings last quarter?

OrganiGram Holdings Inc. (NASDAQ:OGI) announced its quarterly earnings results on Monday, November, 30th. The company reported ($0.03) earnings per share for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.03). The company had revenue of $15.19 million for the quarter, compared to analysts' expectations of $14.77 million. OrganiGram had a negative return on equity of 10.00% and a negative net margin of 207.26%.
View OrganiGram's earnings history

What price target have analysts set for OGI?

12 analysts have issued 12-month target prices for OrganiGram's stock. Their forecasts range from $1.72 to $4.00. On average, they anticipate OrganiGram's share price to reach $2.64 in the next twelve months. This suggests a possible upside of 46.9% from the stock's current price.
View analysts' price targets for OrganiGram
or view Wall Street analyst' top-rated stocks.

Are investors shorting OrganiGram?

OrganiGram saw a drop in short interest in the month of December. As of December 31st, there was short interest totaling 12,820,000 shares, a drop of 19.4% from the December 15th total of 15,910,000 shares. Based on an average daily volume of 7,640,000 shares, the days-to-cover ratio is currently 1.7 days. Approximately 5.6% of the shares of the company are short sold.
View OrganiGram's Short Interest

Who are some of OrganiGram's key competitors?

What other stocks do shareholders of OrganiGram own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OrganiGram investors own include KushCo (KSHB), (CGC), Auxly Cannabis Group (CBWTF), The Supreme Cannabis (SPRWF), Medical Marijuana (MJNA), Cannabics Pharmaceuticals (CNBX), MariMed (MRMD), Aurora Cannabis (ACB), EVIO (EVIO) and Gran Tierra Energy (GTE).

Who are OrganiGram's key executives?

OrganiGram's management team includes the following people:
  • Mr. Gregory Engel, CEO & Director (Age 55)
  • Mr. Derrick W. West CPA, CPA, (CA), Chief Financial Officer (Age 53)
  • Mr. Timothy Emberg, Sr. VP of Sales & Commercial Operations
  • Mr. Paolo De Luca C.A., C.F.A, Chief Strategy Officer (Age 47)
  • Mr. Matt Rogers, Sr. VP of Operations
  • Amy Schwalm, VP of Investor Relations
  • Ms. Helen Martin, Sr. VP of Strategic & Legal Affairs and Company Sec. (Age 42)
  • Mr. James Cavanagh, Chief of Staff
  • Mr. Larry Rogers, VP of International Bus. Devel.
  • Mr. Peter R. Hanson, Director of Fin.

What is OrganiGram's stock symbol?

OrganiGram trades on the NASDAQ under the ticker symbol "OGI."

How do I buy shares of OrganiGram?

Shares of OGI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is OrganiGram's stock price today?

One share of OGI stock can currently be purchased for approximately $1.80.

How big of a company is OrganiGram?

OrganiGram has a market capitalization of $417.76 million and generates $64.61 million in revenue each year. The company earns $-101,290,000.00 in net income (profit) each year or ($0.08) on an earnings per share basis. OrganiGram employs 517 workers across the globe.

What is OrganiGram's official website?

The official website for OrganiGram is www.organigram.ca.

How can I contact OrganiGram?

OrganiGram's mailing address is 35 English Dr., Moncton Z4, E1E 3X3. The company can be reached via phone at 1-855-961-9420.

This page was last updated on 1/16/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.